Objectives: The present study evaluated the effects of a combined nutritional supplement, containing omega-3 fatty acids (ω-3 FA) and different antioxidative micronutrients on nutrient status and disease activity in patients with rheumatoid arthritis (RA). Methods: The study was conducted as a double-blind, randomised placebo-controlled trial. A hundred patients with defined RA were allocated to the verum or placebo group. During a period of twelve weeks they were given three capsules of their specific study supplementation every day. The daily dosage of ω-3 FA was 1.35 g (thereof 900 mg eicosapentaenoic acid, EPA), 90 mg vitamin E, 600 μg vitamin A, 3 mg copper, and 75 μg selenium, or soy oil (placebo), respectively. Outcome variables were the changes in DAS 28, the number of tender and swollen joints, morning stiffness, and supply with different nutrients (e.g. serum concentration of EPA, AA and vitamin E), as well as blood lipid levels. Results: Sixty-four participants were included in this analysis: 30 receiving verum and 34 placebo. After twelve weeks of intervention, little but not significant improvements were observed in the DAS 28 and other clinical factors. Subgroup analysis revealed that the effect was much more pronounced in patients who were at least at a moderate activity of illness. Regarding the nutritional status, the serum concentration of EPA (P < 0.001), vitamin E (P < 0.01), SOD (P < 0.05), and GPx (P < 0.001) increased significantly, while AA (P < 0.001) decreased after supplementation. The concentration of triglycerides decreased significantly in the verum group (P < 0.05) but not in the placebo group. Conclusions: A twelve week add-on supplementation of a combined food supplement (ω-3 FA + antioxidants) effected modest but not significant changes in the clinical parameters in RA. Though vitamin E, SOD and GPx improved significantly, equivalent to an increased antioxidant defence. This supplementation was dedicated to enhance the nutritional status of critical nutrients in RA, especially with regard to an increased risk of cardiovascular disease in these patients.
D. L. Scott, F. Wolfe and T. W. Huizinga, “Rheumatoid Arthritis,” Lancet, Vol. 376, No. 9746, 2010, pp. 1094- 1108.
P. C. Calder, R. Albers, J. M. Antoine, S. Blum, R. Bourdet-Sicard, G. A. Ferns, G. Folkerts, P. S. Friedmann, G. S. Frost, F. Guarner, M. Lovik, S. Macfarlane, P. D. Meyer, L. M’Rabet, M. Serafini, W. van Eden, J. van Loo, W. vas Dias, S. Vidry, B. M. Winklhofer-Roob and J. Zhao, “Inflammatory Disease Processes and Interactions with Nutrition,” British Journal of Nutrition, Vol. 101, No. S1, 2009, pp. S1-S45.
S. D. Walwadkar, A. N. Suryakar, R. V. Katkam, K. M. Kumbar and R. D. Ankush, “Oxidative Stress and Calcium-Phosphorus Levels in Rheumatoid Arthritis,” Indian Journal of Clinical Biochemistry, Vol. 21, No. 2, 2006, pp. 134-137.
Y. Ozkan, S. Yardym-Akaydyn, A. Sepici, E. Keskin, V. epici and B. Simsek, “Oxidative Status in Rheumatoid Arthritis,” Clinical Rheumatology, Vol. 26, No. 1, 2007, pp. 64-68. doi:10.1007/s10067-006-0244-z
L. I. Filippin, R. Vercelino, N. P. Marroni and R. M. Xavier, “Redox Signalling and the Inflammatory Response in Rheumatoid Arthritis,” Clinical and Experimental Immunology, Vol. 152, No. 3, 2008, pp. 415-422. doi:10.1111/j.1365-2249.2008.03634.x
A. Mahajan and V. R. Tandon, “Antioxidants and Rheumatoid Arthritis,” Journal of Indian Rheumatology Association, Vol. 12, No. 4, 2004, pp. 139-142.
V. Afonso, R. Champy, D. Mitrovic, P. Collin and A. Lomri, “Reactive Oxygen Species and Superoxide Dismutases: Role in Joint Diseases,” Joint Bone Spine, Vol. 74, No. 4, 2007, pp. 324-329. doi:10.1016/j.jbspin.2007.02.002
S. Jaswal, H. C. Mehta, A. K. Sood and J. Kaur, “Antioxidant Status in Rheumatoid Arthritis and Role of Antioxidant Therapy,” Clinica Chimica Acta, Vol. 338, No. 1-2, 2003, pp. 123-129. doi:10.1016/j.cccn.2003.08.011
A. Kamanli, M. Naziroglu, N. Aydilek and C. Hacievliyagil, “Plasma Lipid Peroxidation and Antioxidant Levels in Patients with Rheumatoid Arthritis,” Cell Biochemistry and Function, Vol. 22, No. 1, 2004, pp. 53-57. doi:10.1002/cbf.1055
F. Karatas, I. Ozates, H. Canatan, I. Halifeoglu, M. Karatepe and R. Colakt, “Antioxidant Status & Lipid Per- oxidation in Patients with Rheumatoid Arthritis,” Indian Journal of Medical Research, Vol. 118, 2003, pp. 178- 181.
P. Pasupathi, M. Deepa, P. Rani and R. R. Sankar, “Circulating Lipid Peroxidation, Plasma and Erythrocyte Antioxidant Status in Patients with Rheumatoid Arthritis,” Bangladesh Medical Research Council Bulletin, Vol. 35, No. 2, 2009, pp. 57-62. doi:10.3329/bmrcb.v35i2.2798
S. C. Bae, S. J. Kim and M. K. Sung, “Inadequate Antioxidant Nutrient Intake and Altered Plasma Antioxidant Status of Rheumatoid Arthritis Patients,” Journal of the American College of Nutrition, Vol. 22, No. 4, 2003, pp. 311-315.
S. L. Morgan, A. M. Anderson, S. M. Hood, P. A. Matthews, J. Y. Lee and G. S. Alarcon, “Nutrient Intake Patterns, Body Mass Index, and Vitamin Levels in Patients with Rheumatoid Arthritis,” Arthritis Care & Research, Vol. 10, No. 1, 1997, pp. 9-17. doi:10.1002/art.1790100103
D. H. Solomon, E. W. Karlson, E. B. Rimm, C. C. Cannuscio, L. A. Mandl, J. E. Manson, M. J. Stampfer and G. C. Curhan, “Cardiovascular Morbidity and Mortality in Women Diagnosed with Rheumatoid Arthritis,” Circu- lation, Vol. 107, No. 9, 2003, pp. 1303-1307.
N. Goodson, J. Marks, M. Lunt and D. Symmons, “Cardiovascular Admissions and Mortality in an Inception Cohort of Patients with Rheumatoid Arthritis with Onset in the 1980s and 1990s,” Annals of the Rheumatic Diseases, Vol. 64, No. 11, 2005, pp. 1595-1601. doi:10.1136/ard.2004.034777
C. P. Chung, A. Oeser, P. Raggi, T. Gebretsadik, A. K. Shintani, T. Sokka, T. Pincus, I. Avalos and C. M. Stein, “Increased Coronary-Artery Atherosclerosis in Rheumatoid Arthritis: Relationship to Disease Duration and Cardiovascular Risk Factors,” Arthritis & Rheumatism, Vol. 52, No. 10, 2005, pp. 3045-3053.
M. Peters, D. Symmons, D. McCarey, B. Dijkmans, P. Nicola, T. Kvien, I. B. McInnes, H. Haentzschel, M. A. Gonzalez-Gay, S. Provan, A. G. Semb, P. Sidiropoulos, G. Kitas, Y. M. Smulders, M. J. Soubrier, Z. Szekanecz, N. G. Sattar and M. T. Nurmohamed, “Eular Evidence- Based Recommendations for Cardiovascular Risk Management in Patients with Rheumatoid Arthritis and Other Forms of Inflammatory Arthritis,” Annals of the Rheumatic Diseases, Vol. 69, No. 2, 2010, pp. 325-331. doi:10.1136/ard.2009.113696
P. A. Bacon and J. N. Townend, “Nails in the Coffin: Increasing Evidence for the Role of Rheumatic Disease in the Cardiovascular Mortality of Rheumatoid Arthritis,” Arthritis & Rheumatism, Vol. 44, No. 2, 2001, pp. 2707- 2710.
R. J. Goldberg and J. Katz, “A Meta-Analysis of the Analgesic Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation for Inflammatory Joint Pain,” Pain, Vol. 129, No. 1-2, 2007, pp. 210-223.
P. R. Fortin, R. A. Lew, M. H. Liang, E. A. Wright, L. A. Beckett, T. C. Chalmers and R. I. Sperling, “Validation of a Meta-Analysis: The Effects of Fish Oil in Rheumatoid Arthritis,” Journal of Clinical Epidemiology, Vol. 48, No. 11, 1995, pp. 1379-1390. doi:10.1016/0895-4356(95)00028-3
L. K. Stamp, M. J. James and L. G. Cleland, “Diet and Rheumatoid Arthritis: A Review of the Literature,” Seminars in Arthritis and Rheumatism, Vol. 35, No. 2, 2005, pp. 77-94. doi:10.1016/j.semarthrit.2005.05.001
C. von Schacky and W. Harris, “Cardiovascular Benefits of Omega-3 Fatty Acids,” Cardiovascular Research, Vol. 73, No. 2, 2007, pp. 310-315. doi:10.1016/j.cardiores.2006.08.019
S. C. Smith Jr., J. Allen, S. N. Blair, R. O. Bonow, L. M. Brass, G. C. Fonarow, S. M. Grundy, L. Hiratzka, D. Jones, H. M. Krumholz, L. Mosca, R. C. Pasternak, T. Pearson, M. A. Pfeffer and K. A. Taubert, “AHA/ACC Guidelines for Secondary Prevention for Patients with Coronary and Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the National Heart, Lung, and Blood Institute,” Circulation, Vol. 113, No. 19, 2006, pp. 2363-2372.
P. H. Canter, B. Wider and E. Ernst, “The Antioxidant Vitamins A, C, E and Selenium in the Treatment of Arthritis: A Systematic Review of Randomized Clinical Trials,” Rheumatology, Vol. 46, No. 8, 2007, pp. 1223-1233.
S. C. Bae, W. J. Jung, E. J. Lee, R. Yu and M. K. Sung, “Effects of Antioxidant Supplements Intervention on the Level of Plasma Inflammatory Molecules and Disease Severity of Rheumatoid Arthritis Patients,” Journal of the American College of Nutrition, Vol. 28, No. 1, 2009, pp. 56-62.
G. Keyber, “Are There Effective Dietary Recommendations for Patients with Rheumatoid Arthritis?” Zeitschrift für Rheumatologie, Vol. 60, No. 1, 2001, pp. 17-27.
P. M. Welsing, J. Fransen and P. L. van Riel, “Is the Disease Course of Rheumatoid Arthritis Becoming Milder? Time Trends since 1985 in an Inception Cohort of Early Rheumatoid Arthritis,” Arthritis & Rheumatism, Vol. 52, No. 9, 2005, pp. 2616-2624.
B. F. Leeb, J. Sautner, I. Andel and B. Rintelen, “Intravenous Application of Omega-3 Fatty Acids in Patients with Active Rheumatoid Arthritis. The ORA-1 Trial. An Open Pilot Study,” Lipids, Vol. 41, 2006, pp. 29-34.
P. H. Remans, J. K. Sont, L. W. Wagenaar, W. Wouters-Wesseling, W. M. Zuijderduin, A. Jongma, F. C. Breedveld and J. M. van Laar, “Nutrient Supplementation with Polyunsaturated Fatty Acids and Micronutrients in Rheumatoid Arthritis: Clinical and Biochemical Effects,” European Journal of Clinical Nutrition, Vol. 58, 2004, pp. 839-845. doi:10.1038/sj.ejcn.1601883
P. Geusens, C. Wouters, J. Nijs, Y. Jiang and J. Dequeker, “Long-Term Effect of Omega-3 Fatty Acid Supplementation in Active Rheumatoid Arthritis. A 12-Month, Double-Blind, Controlled Study,” Arthritis & Rheumatism, Vol. 37, No. 6, 1994, pp. 824-829.
J. M. Kremer, D. A. Lawrence, W. Jubiz, R. DiGiacomo, R. Rynes, L. E. Bartholomew and M. Sherman, “Dietary Fish Oil and Olive Oil Supplementation in Patients with Rheumatoid Arthritis. Clinical and Immunologic Effects,” Arthritis & Rheumatism, Vol. 33, No. 6, 1990, pp. 810- 820.
J. M. Kremer, D. A. Lawrence, G. F. Petrillo, L. L. Litts, P. M. Mullaly, R. I. Rynes, R. P. Stocker, N. Parhami, N. S. Greenstein and B. R. Fuchs, “Effects of High-Dose Fish Oil on Rheumatoid Arthritis after Stopping Nonsteroidal Antiinflammatory Drugs. Clinical and Immune Correlates,” Arthritis & Rheumatism, Vol. 38, No. 8, 1995, pp. 1107-1114.
J. M. Kremer, “n-3 Fatty Acid Supplements in Rheumatoid Arthritis,” American Journal of Clinical Nutrition, Vol. 71, No. S1, 2000, pp. 349S-351S.
G. W. Comstock, A. E. Burke, S. C. Hoffman, K. J. Helzlsouer, A. Bendich, A. T. Masi, E. P. Norkus, R. L. Malamet and M. E. Gershwin, “Serum Concentrations of Alpha Tocopherol, Beta Carotene, and Retinol Preceding the Diagnosis of Rheumatoid Arthritis and Systemic Lupus Erythematosus,” Annals of the Rheumatic Diseases, Vol. 56, No. 5, 1997, pp. 323-325. doi:10.1136/ard.56.5.323
M. Yazar, S. Sarban, A. Kocyigit and U. E. Isikan, “Synovial Fluid and Plasma Selenium, Copper, Zinc, and Iron Concentrations in Patients with Rheumatoid Arthritis and Osteoarthritis,” Biological Trace Element Research, Vol. 106, No. 2, 2005, pp. 123-132. doi:10.1385/BTER:106:2:123
C. D. Thomson, “Assessment of Requirements for Selenium and Adequacy of Selenium Status: A Review,” European Journal of Clinical Nutrition, Vol. 58, 2004, pp. 391-402. doi:10.1038/sj.ejcn.1601800
M. Helmy, M. Shohayeb, M. H. Helmy and E. A. El-Bassiouni, “Antioxidants as Adjuvant Therapy in Rheumatoid Disease. A Preliminary Study,” Arzneimittelforschung, Vol. 51, No. 4, 2001, pp. 293-298.
M. Nivsarkar, “Improvement in Circulating Superoxide Dismutase Levels: Role of Nonsteroidal Anti-Infla- mmatory Drugs in Rheumatoid Arthritis,” Biochemical and Biophysical Research Communications, Vol. 270, No. 3, 2000, pp. 714-716. doi:10.1006/bbrc.2000.2503
P. M. Kris-Etherton, W. S. Harris and L. J. Appel, “Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease,” Circulation, Vol. 106, 2002, pp. 2747-2757.
W. S. Harris, “n-3 Fatty Acids and Serum Lipoproteins: Human Studies,” American Journal of Clinical Nutrition, Vol. 65, No. 5, 1997, pp. 1645S-1654S.